Detalhe da pesquisa
1.
Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment.
Haematologica
; 109(3): 777-786, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731379
2.
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.
Hematol Oncol
; 42(4): e3293, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38872511
3.
Toxicity of CAR T-Cell Therapy for Multiple Myeloma.
Acta Haematol
; : 1-15, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38718775
4.
Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma: U.S. Myeloma Immunotherapy Consortium real world experience.
Haematologica
; 2023 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855036
5.
Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma.
Eur J Haematol
; 110(6): 626-632, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36752328
6.
Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences.
Breast J
; 2022: 1447545, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36685664
7.
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(11): 2197-2203, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30016656
8.
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant
; 23(4): 581-587, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28063964
9.
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.
Transpl Infect Dis
; 19(1)2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27862740
10.
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 21(8): 1413-7, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25842049
11.
Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(11): 1767-71, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25017763
12.
Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
Ann Surg Oncol
; 21(11): 3466-72, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24796968
13.
Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience.
Transplant Cell Ther
; 30(3): 308.e1-308.e13, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151105
14.
Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel.
J Hematol Oncol
; 17(1): 42, 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38845015
15.
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy.
Blood Adv
; 8(1): 251-259, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855718
16.
Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: The US Myeloma Immunotherapy Consortium Real- World Experience.
Transplant Cell Ther
; 2024 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834151
17.
Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy.
Cancers (Basel)
; 15(11)2023 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296856
18.
Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab-Naïve Relapsed Multiple Myeloma.
Cancers (Basel)
; 15(19)2023 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37835587
19.
Clinical and molecular characteristics associated with Vitamin C deficiency in myeloid malignancies; real world data from a prospective cohort.
Leuk Res
; 125: 107001, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36566538
20.
Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.
J Clin Oncol
; 41(11): 2087-2097, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623248